Walgreens Boots Alliance has reported a narrower-than-expected loss of $178 million in its third quarter as the pharmacy chain approaches the completion of its sale to investment firm Sycamore Partners for over $10 billion. The third quarter results, ending on May 31, showed a 7% increase in sales to $39 billion, but a loss of $175 million compared to a net earnings of $344 million in the previous year. The loss was attributed to various factors including prior year gains and higher tax expenses.
The sale to Sycamore Partners, which offers $11.45 per share, represents a 29% increase above the stock price in December. This deal follows a period of pharmacy closures and declining stock prices for Walgreens, partly due to the unsuccessful rollout of clinics attached to its stores.
Walgreens CEO, Tim Wentworth, acknowledged the challenges faced by the company but highlighted the improvement in the U.S. Healthcare segment and cost-saving initiatives. However, front-end sales in the U.S. Retail Pharmacy segment decreased by 5%, leading to a 30% decrease in adjusted operating income.
The sale agreement with Sycamore Partners includes the potential for additional cash per share from the future monetization of Walgreens’ interests in VillageMD, its primary care businesses. The total value of the deal, including debt and other items, exceeds $23 billion.
The third quarter results mark an improvement from the previous quarter when Walgreens reported a $2.8 billion loss, mainly due to impairment charges related to its investment in VillageMD. The company’s focus on reducing debt and financial losses led to the closure of several stores.
Under former CEO Roz Brewer, Walgreens invested billions in VillageMD to establish physician-staffed clinics within its stores. However, the company has scaled back on this expansion, focusing on building a sustainable business model. Despite the challenges, Walgreens remains committed to its turnaround plan and navigating the evolving pharmacy and retail landscape.
For the nine-month period ending on May 31, Walgreens reported a loss of over $3.2 billion. The company continues to adapt to changing market conditions and strategic partnerships to drive growth and profitability.
